Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 1:44 pm Unchanged |
2022-12-31 | 13G | Disc Medicine, Inc. IRON |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 1:31 pm Purchase |
2022-12-31 | 13G | Biohaven Ltd. BHVN |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,848,938 5.700% |
8,600 (+0.22%) |
Filing History |
| 2023-02-13 1:21 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT LLC | 36,822,190 5.900% |
-8,888,145 (-19.44%) |
Filing History |
| 2023-02-13 1:07 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT LLC | 6,376,815 9.300% |
2,804,396 (+78.50%) |
Filing History |
| 2023-02-13 12:36 pm Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-2,230,250 (Position Closed) |
Filing History |
| 2023-02-13 12:25 pm Purchase |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT LLC | 372,276 9.990% |
327,041 (+722.98%) |
Filing History |
| 2023-02-13 12:01 pm Sale |
2022-12-31 | 13G | InflaRx N.V. IFRX |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,146,240 4.900% |
-4,138,760 (-65.85%) |
Filing History |
| 2023-02-13 10:56 am Purchase |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
SUVRETTA CAPITAL MANAGEMENT LLC | 5,565,099 9.700% |
3,091,304 (+124.96%) |
Filing History |
| 2023-02-13 10:51 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT LLC | 1,072,302 3.100% |
-673,998 (-38.60%) |
Filing History |
| 2023-02-13 10:47 am Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-4,948,000 (Position Closed) |
Filing History |
| 2023-02-13 10:40 am Sale |
2022-12-31 | 13G | Cano Health, Inc. CANO |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-105,476 (Position Closed) |
Filing History |
| 2023-02-13 10:34 am Sale |
2022-12-31 | 13G | Arcellx, Inc. ACLX |
SUVRETTA CAPITAL MANAGEMENT LLC | 2,350,333 5.400% |
-120,226 (-4.87%) |
Filing History |
| 2023-02-13 10:27 am Purchase |
2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
SUVRETTA CAPITAL MANAGEMENT LLC | 350,426 5.100% |
36,246 (+11.54%) |
Filing History |
| 2023-02-13 10:23 am Sale |
2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT LLC | 3,411,210 9.990% |
-70,899 (-2.04%) |
Filing History |
| 2023-02-13 10:15 am Purchase |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
SUVRETTA CAPITAL MANAGEMENT LLC | 4,274,803 8.200% |
1,899,232 (+79.95%) |
Filing History |
| 2023-02-13 10:11 am Purchase |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT LLC | 4,971,660 9.990% |
2,332,885 (+88.41%) |
Filing History |
| 2023-02-13 08:53 am Sale |
2022-12-31 | 13G | Sio Gene Therapies Inc. SIOX |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-5,914,000 (Position Closed) |
Filing History |
| 2023-02-13 08:49 am Sale |
2022-12-31 | 13G | Otonomy, Inc. OTIC |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
-5,993,689 (Position Closed) |
Filing History |
| 2023-02-13 08:45 am Unchanged |
2022-12-31 | 13G | Solid Biosciences Inc. SLDB |
SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-13 08:41 am Purchase |
2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
SUVRETTA CAPITAL MANAGEMENT LLC | 255,055 9.990% |
152,215 (+148.01%) |
Filing History |